Samy Y. Lamouille

Dr. Lamouille has a demonstrated track record as a leader in both academia and the biotech business sector. He is an experienced cell and molecular biologist with 20+ years of experience in the cancer field, including 8+ years working in biotech companies in San Francisco, CA and Roanoke, VA. He completed his PhD at the University of Grenoble, France, and postdoctoral training at University of California San Francisco. He has made significant discoveries in the field of cancer progression through metastasis, and has published in leading journals, including Nature Biotechnology, Nature Reviews, and Cancer Research. In 2016, he co-founded Acomhal Research to develop novel cancer treatments to prevent tumor recurrence and metastasis. The following year, the Association of Public and Land-grant Universities selected Acomhal Research as one of 22 companies nationwide for the University Innovation and Entrepreneurship Showcase at the Rayburn House Office Building in Washington, DC. Dr. Lamouille has served as PI on multiple SBIR/STTR grants and has recently raised capital via a seed fund round with Virginia Investors to support Acomhal’s mission.